Aromatase Inhibitor-Induced Erythrocytosis in a Patient Undergoing Hormonal Treatment for Breast Cancer

Aromatase inhibitors (AIs) are most commonly used for breast cancer patients with hormone receptor positive disease. Although the side effect profile of aromatase inhibitors is well known, including common side effects like arthralgia, bone pain, arthritis, hot flashes, and more serious problems lik...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeruva, Sri Lakshmi Hyndavi, Nwabudike, Stanley Madu, Ogbonna, Onyekachi Henry, Oneal, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468297/
https://www.ncbi.nlm.nih.gov/pubmed/26137331
http://dx.doi.org/10.1155/2015/784783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468297/
https://www.ncbi.nlm.nih.gov/pubmed/26137331
http://dx.doi.org/10.1155/2015/784783

Ejemplares similares